Summer school and conference: Applications of Nanodrugs in Photodynamic Therapy
April 9-12, 2013
Our work has been highlighted in Current Optinion in Immunology by Stefan F. Martin.
The first in vivo targets of haptenation in human skin were identified in an elegant study. Caged fluorescent haptens, thiol reactive bromobimanes, were used to detect target proteins in full thickness human skin 20 h after application using two photon fluorescence microscopy [Simonsson et al, 2011].
Martin, S.F., (2012), Allergic contact dermatitis: Xenoinflammation of the skin. Current Opinion in Immunology 24, 720-729.